Your browser doesn't support javascript.
loading
Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib.
Germa, C; Miller, M; Mukhopadhyay, P; Hewes, B; Caponigro, G; Scherer, S J; Hirawat, S.
Affiliation
  • Germa C; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover.
  • Miller M; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover.
  • Mukhopadhyay P; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover.
  • Hewes B; Novartis Institutes for BioMedical Research, Cambridge, USA.
  • Caponigro G; Novartis Institutes for BioMedical Research, Cambridge, USA.
  • Scherer SJ; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover.
  • Hirawat S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover.
Ann Oncol ; 28(8): 2021-2024, 2017 08 01.
Article in En | MEDLINE | ID: mdl-28838206
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Breast Neoplasms / Aminopyridines Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Breast Neoplasms / Aminopyridines Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: